Financial Results
Cravatex Reports Q2 FY27 Results
Cravatex approved unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, along with the limited review report.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
6
Neutral
6
Bullish
2
Bearish
18
Neutral
6
Bullish
22
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
Commercial Services & Supplies
Trading & Distributors
79 Cr
High Risk
9.1
19.9
0.2
0.7
435.80
279.60
Sales CAGR
Profit CAGR
ROE
ROCE
Cravatex Ltd (CRAVATEX) is currently trading at 342.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Cravatex Limited is a holding company engaged in the distribution of sports goods and fitness equipment, representing respected international brands such as Fila and Johnson. Originally founded in 1951, Cravatex has expanded into various sectors, including beauty therapy with advanced services and products, while maintaining its core sports and fitness equipment business. The company is ISO certified—unique among public listed firms in its field in India, enhancing its credibility and operational standards. Cravatex's strategic move into the beauty therapy sector is a diversification away from its traditional products, aiming to capture the growing wellness market. Proline Fitness, launched by Cravatex, pioneered personal fitness equipment in India, maintaining an exclusive distributorship with several leading global fitness brands.
Over the past 52 weeks, Cravatex Ltd has traded between a low of ₹279.60 and a high of ₹435.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Cravatex Ltd has a market capitalization of approximately 78.69. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Cravatex Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 9.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 78.69 Cr, Cravatex Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Cravatex Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Cravatex Ltd is 9.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Cravatex reported consolidated revenue of ₹32.22 crore for the April-June 2026 quarter. This was 39.30% higher than the roughly ₹23 crore reported in the corresponding quarter a year earlier.
Cravatex reported consolidated total income of ₹167.69 crore for FY2025-26 and consolidated net profit of ₹6.80 crore for the same period.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
